4523 Eisai
- 6666.0
- -69.0-1.02%
Eisai News
Eisai: Notice of Convocation of the 112th Annual General Meeting of Shareholders (2024)
Eisai: Notice of Convocation of the 112th (2024) Annual General Meeting of Shareholders and Shareholders' Meeting Materials
Eisai: Independent Officer Notification Form
Eisai: 2023 financial results briefing materials
Eisai: FY2023 (ended 2024/3/31) full-year financial results reference data
Eisai: Consolidated financial report for fiscal year 2023 (year ended March 31, 2024) [IFRS]
Eisai: Eisai announces repurchase of treasury stock and cancellation of treasury stock
Eisai: Notice regarding candidates for directors and executive officers
Eisai: Notice regarding the appointment of new representative officers
Eisai: Notice Concerning Decisions on Matters Relating to Repurchase of Own Shares and Cancellation of Treasury Shares
Eisai: Notice regarding the election of candidates for directors and candidates for executive officers
Eisai: FY2023 (FY2024/3) full-year financial results reference materials
Eisai: Notice regarding changes in representative executive officers
Eisai: Summary of financial results for the fiscal year ending 2024/3 [IFRS] (consolidated)
Eisai: Statutory ex post facto disclosure documents (mergers and acquisitions) (Kan Laboratories Co., Ltd.)
Eisai: Notice of the Settlement of Patent Infringement Litigation Related to Lenvatinib in the U.S.
Eisai: Settlement of patent infringement lawsuits relating to lenvatinib in the United States
Eisai: 2023 “Press Conference” materials
Eisai: Confirmation
Eisai: Quarterly Report - 112th Quarter (2023/10/01 - 2023/12/31)
Analysis
Price Target
No Data
